Murali Kannan MARUTHAMUTHU

Dr. Murali Kannan MARUTHAMUTHU

UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2021 in Veterinary Research
Verified
Journal Article
Open access
PDF file
APAna Pascual-Garrigos
Ana Pascual-Garrigos
Murali Kannan MARUTHAMUTHUMurali Kannan MARUTHAMUTHU
Murali Kannan MARUTHAMUTHU
AAAaron Ault
Aaron Ault
JDJosiah Levi Davidson
Josiah Levi Davidson
GRGrigorii Rudakov
Grigorii Rudakov
MVMohit Verma
Mohit Verma
This work modifies a loop-mediated isothermal amplification (LAMP) assay to detect the bovine respiratory disease (BRD) bacterial pathogens Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni in a colorimetric format on a farm. BRD causes a significant health and economic burden worldwide that partially stems from the challenges involved in determining the pathogens causing the disease. Methods such as polymerase chain reaction (PCR) have the potential to identify the causative pathogens but require lab equipment and extensive sample processing making the process lengthy and expensive. To combat this limitation, LAMP allows accurate pathogen detection in unprocessed samples by the naked eye allowing for potentially faster and more precise diagnostics on the farm. The assay developed here offers 66.7–100% analytical sensitivity, and 100% analytical specificity (using contrived samples) while providing 60–100% concordance with PCR results when tested on five steers in a feedlot. The use of a consumer-grade water bath enabled on-farm execution by collecting a nasal swab from cattle and provided a colorimetric result within 60 min. Such an assay holds the potential to provide rapid pen-side diagnostics to cattle producers and veterinarians.

20 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AKArulsamy Kulandaisamy
Arulsamy Kulandaisamy
PMPanneerselvam Murugesan
Panneerselvam Murugesan
VRVijay Solomon Rajadurai
Vijay Solomon Rajadurai
MJMadhavan Jaccob
Madhavan Jaccob
Jaganathan RamakrishnanJaganathan Ramakrishnan
Jaganathan Ramakrishnan
DTDr. Nagendran Tharmalingam
Dr. Nagendran Tharmalingam
The high expression of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) mRNA has been found in breast cancer tissues and endometriosis. The current research focuses on preparing a range of organic molecules as 17β-HSD1 inhibitors. Among them, the derivatives of hydroxyphenyl naphthol steroidomimetics are reported as one of the potential groups of inhibitors for treating estrogen-dependent disorders. Looking at the recent trends in drug design, many halogen-based drugs have been approved by the FDA in the last few years. Here, we propose sixteen potential hydroxyphenyl naphthol steroidomimetics-based inhibitors through halogen substitution. Our Frontier Molecular Orbitals (FMO) analysis reveals that the halogen atom significantly lowers the Lowest Unoccupied Molecular Orbital (LUMO) level, and iodine shows an excellent capability to reduce the LUMO in particular. Tri-halogen substitution shows more chemical reactivity via a reduced HOMO–LUMO gap. Furthermore, the computed DFT descriptors highlight the structure–property relationship towards their binding ability to the 17β-HSD1 protein. We analyze the nature of different noncovalent interactions between these molecules and the 17β-HSD1 using molecular docking analysis. The halogen-derived molecules showed binding energy ranging from −10.26 to −11.94 kcal/mol. Furthermore, the molecular dynamics (MD) simulations show that the newly proposed compounds provide good stability with 17β-HSD1. The information obtained from this investigation will advance our knowledge of the 17β-HSD1 inhibitors and offer clues to developing new 17β-HSD1 inhibitors for future applications.